DNA Damage/DNA Repair
Research Areas
- MTH1(4)
- PARP(103)
- ATM/ATR(31)
- DNA Alkylating(23)
- DNA Ligases(3)
- DNA Methyltransferase(27)
- DNA-PK(28)
- HDAC(143)
- Nucleoside Antimetabolite/Analogue(194)
- Telomerase(15)
- Topoisomerase(193)
- tankyrase(5)
- Antifolate(33)
- CDK(299)
- Checkpoint Kinase (Chk)(36)
- CRISPR/Cas9(9)
- Deubiquitinase(84)
- DNA Alkylator/Crosslinker(87)
- DNA/RNA Synthesis(575)
- Eukaryotic Initiation Factor (eIF)(33)
- IRE1(25)
- LIM Kinase (LIMK)(12)
- TOPK(6)
- Casein Kinase(59)
- DNA Intercalating Agents(8)
- DNA/RNA Oxidative Damage(13)
- Poly(ADP-ribose) Glycohydrolase (PARG)(5)
- Early 2 Factor (E2F)(2)
- Zinc Finger Protein(1)
Products Related to DNA Damage/DNA Repair(1968)
- GC10322Tubastatin A HClCAS: 1310693-92-5Purity: >98.00%
Tubastatin A HCl (Tubastatin A HCl) is a potent and selectiveHDAC6inhibitor withIC50of 15 nM in a cell-free assay, and is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more). Tubastatin A HCl also inhibits HDAC10 and metallo-β-lactamase domain-containing protein2 (MBLAC2).
- GC10637ZidovudineCAS: 30516-87-1Purity: >99.50%
Zidovudine is a synthetic nucleoside analog that blocks replication of the human immunodeficiency virus (HIV) by inhibiting reverse transcriptase.
- GC10686Epirubicin HClCAS: 56390-09-1Purity: >98.00%
Epirubicin HCl (4'-Epidoxorubicin hydrochloride), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase. Epirubicin HCl inhibits DNA and RNA synthesis. Epirubicin HCl is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity.
- GC11114Moxifloxacin HClCAS: 186826-86-8Purity: >99.50%
Moxifloxacin HCl (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
- GC11473IrinotecanCAS: 97682-44-5Purity: >98.00%
Irinotecan is a topoisomerase inhibitor used primarily for the treatment of colorectal cancer. Irinotecan binds to the topoisomerase I-DNA complex, preventing DNA strand reconnection and leading to DNA double-strand breaks and cell death.
- GC11537MK-4827 tosylateCAS: 1038915-73-9Purity: >99.50%
MK-4827 tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. MK-4827 tosylate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity.
- GC11619Dexrazoxane HCl (ICRF-187, ADR-529)CAS: 149003-01-0Purity: >98.50%
Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent
- GC12756MK-4827 hydrochlorideCAS: 1038915-64-8Purity: >99.50%
MK-4827 hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. MK-4827 hydrochloride leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity.
- GC13667TemozolomideCAS: 85622-93-1Purity: >98.50%
Temozolomide is an oral activity alkylating agent that induces the formation of O6-methylguanine in DNA, which mispairs with thymine during the following cycle of DNA replication, leading to activation of the apoptotic pathways, Temozolomide could crosses the blood-brain barrier and is indicated for malignant gliomas and metastatic melanomas.
- GC13831FT-207 (NSC 148958)CAS: 17902-23-7Purity: >99.50%
FT-207 (NSC 148958) (FT 207; NSC 148958) is a chemotherapeutic 5-FU prodrug used in the treatment of cancers; is a component of tegafur-uracil.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10196 | ETP-46464 | 1345675-02-6 | >98.00% | |
ATR inhibitor,potent and selective | ||||
| GC10293 | VE-821 | 1232410-49-9 | >98.50% | |
ATR kinase inhibitor | ||||
| GC10322 | Tubastatin A HCl | 1310693-92-5 | >98.00% | |
Tubastatin A HCl (Tubastatin A HCl) is a potent and selectiveHDAC6inhibitor withIC50of 15 nM in a cell-free assay, and is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more). Tubastatin A HCl also inhibits HDAC10 and metallo-β-lactamase domain-containing protein2 (MBLAC2). | ||||
| GC10637 | Zidovudine | 30516-87-1 | >99.50% | |
Zidovudine is a synthetic nucleoside analog that blocks replication of the human immunodeficiency virus (HIV) by inhibiting reverse transcriptase. | ||||
| GC10686 | Epirubicin HCl | 56390-09-1 | >98.00% | |
Epirubicin HCl (4'-Epidoxorubicin hydrochloride), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase. Epirubicin HCl inhibits DNA and RNA synthesis. Epirubicin HCl is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity. | ||||
| GC11019 | Amonafide | 69408-81-7 | >99.50% | |
DNA intercalator,Topo II inhibitor | ||||
| GC11114 | Moxifloxacin HCl | 186826-86-8 | >99.50% | |
Moxifloxacin HCl (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia. | ||||
| GC11424 | Valproic acid | 99-66-1 | >98.00% | |
HDAC1 inhibitor | ||||
| GC11473 | Irinotecan | 97682-44-5 | >98.00% | |
Irinotecan is a topoisomerase inhibitor used primarily for the treatment of colorectal cancer. Irinotecan binds to the topoisomerase I-DNA complex, preventing DNA strand reconnection and leading to DNA double-strand breaks and cell death. | ||||
| GC11528 | Orotic acid | 65-86-1 | >98.00% | |
Pyrimidinecarboxylic acid | ||||
| GC11537 | MK-4827 tosylate | 1038915-73-9 | >99.50% | |
MK-4827 tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. MK-4827 tosylate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity. | ||||
| GC11548 | Tankyrase Inhibitors (TNKS) 49 | - | >98% | |
Tankyrase inhibitor | ||||
| GC11619 | Dexrazoxane HCl (ICRF-187, ADR-529) | 149003-01-0 | >98.50% | |
Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent | ||||
| GC12292 | Ofloxacin | 82419-36-1 | >99.50% | |
Fluoroquinolones,antibiotics | ||||
| GC12332 | NU 7026 | 154447-35-5 | >99.50% | |
DNPK inhibitor,ATP-competitive and potent | ||||
| GC12756 | MK-4827 hydrochloride | 1038915-64-8 | >99.50% | |
MK-4827 hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. MK-4827 hydrochloride leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity. | ||||
| GC13136 | (S)-Crizotinib | 1374356-45-2 | >99.50% | |
Potent MTH1 inhibitor | ||||
| GC13419 | ME0328 | 1445251-22-8 | >99.50% | |
PARP inhibitor,potent and selective | ||||
| GC13432 | Adenine | 73-24-5 | >98.50% | |
High affinity adenine receptor agonist | ||||
| GC13636 | BIBR 1532 | 321674-73-1 | >99.50% | |
BIBR 1532 is a potent small molecule inhibitor of human telomerase, with an IC 50 value of 5μM for telomerase inhibition. BIBR 1532 causes telomeres to shorten and reduces tumor cell proliferation. | ||||
| GC13667 | Temozolomide | 85622-93-1 | >98.50% | |
Temozolomide is an oral activity alkylating agent that induces the formation of O6-methylguanine in DNA, which mispairs with thymine during the following cycle of DNA replication, leading to activation of the apoptotic pathways, Temozolomide could crosses the blood-brain barrier and is indicated for malignant gliomas and metastatic melanomas. | ||||
| GC13671 | Busulfan | 55-98-1 | >97.00% | |
Busulfan is an alkylating drug alkylates DNA, with an IC 50 value of 77μM for human serum Paraoxonase 1. | ||||
| GC13729 | Cytidine | 65-46-3 | >98.00% | |
pyrimidine nucleoside | ||||
| GC13831 | FT-207 (NSC 148958) | 17902-23-7 | >99.50% | |
FT-207 (NSC 148958) (FT 207; NSC 148958) is a chemotherapeutic 5-FU prodrug used in the treatment of cancers; is a component of tegafur-uracil. | ||||
